References Atanasovski, A
To understand how Acetyl-L-Carnitine (ALCAR) functions, we must first look at its foundational molecule: L-carnitine
The SUSTAIN 6 trial showed that subcutaneous semaglutide reduced major adverse cardiovascular events by 26% in patients with type 2 diabetes and established cardiovascular disease (hazard ratio 0.74, 95% CI 0.58-0.95)
another barrier-enhancing mechanism is where Akkermansia induces Paneth cells to produce antimicrobial peptides, and SCFAs from intestinal mucin glycoproteins are absorbed in the colon as an energy source for colonic cells, inducing regulatory T cells and exerting anti-inflammatory effects (Reunanen et al., 2015
The results were announced today at the annual meeting of the American Diabetes Association and published in the New England Journal of Medicine
It's widely used today in research and wellness settings for body composition, recovery, and healthy aging